Department of Surgery, Houston Methodist Hospital, Houston, Texas (Drs Tran, Rizk, Aryal, and Swan); Department of Pharmacy, Houston Methodist Hospital, Houston, Texas (Drs Tran, Rizk, Aryal, and Swan); Department of Nursing, Houston Methodist Hospital, Houston, Texas (Mr Soto); Center for Outcomes Research, Houston Methodist Hospital, Houston, Texas (Dr Swan).
Corresponding Author: Joshua T. Swan, PharmD, MPH, FCCM, BCPS, Department of Surgery, Houston Methodist Hospital, 6550 Fannin St, SM1661, Houston, TX 77030 ([email protected]).
Disclosures: Under the direction of the principal investigator, Joshua T. Swan, PharmD, MPH, this work was supported by Genentech, Inc (South San Francisco, CA; research grant No. ML41598), a pharmaceutical company that manufactures and sells Cathflo® Activase® (alteplase) in the United States. The funding agency was not involved in the study design, data collection, data analysis, data interpretation, or the development of this manuscript. The authors do not have any additional financial disclosures that are related to this research.
Author Contributions: E.R. and J.T.S. conceived the study design, developed the study protocol, and obtained research funding. A.T.T., E.R., and J.T.S. developed data collection tools and analyzed the data. A.T.T. and D.K.A. collected data. A.T.T. managed the study database and drafted the manuscript. F.J.S. provided clinical expert opinion. All authors revised the manuscript and approved the final version of the manuscript.
